Patient-reported outcomes and health status associated with chronic graft-versus-host disease

Abstract excerpt

Chronic graft-versus-host disease occurs in 20–50% of allogeneic hematopoietic cell transplant survivors. We surveyed patients about their quality of life, symptoms, health status, comorbid conditions and medications. Instruments included the Short-Form-36 (SF-36), the Patient-Reported Outcomes Measurement Information System (PROMIS) Global and PROMIS-29 scales and the Lee Chronic Graft-versus-Host Disease...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Childhood Cancer Survivors' Quality of Life
• Share to Hematopoietic Stem Cell Transplantation
• Share to Mesenchymal stem cell research